Actelis Networks Stock Skyrockets 700% After Securing New US Military Orders
The company's products feature 256-bit MACsec encryption and data fragmentation, enhancing security for IoT devices at the network edge.
What’s Happening With Chinese EV Maker Nio’s Stock On Wednesday?
Nio is set to boost its production capacity with the approval for a third factory in China, elevating its annual production capability to nearly 1 million vehicles. This expansion, aimed at competing with Tesla, addresses growing demand for Nio and its new budget brand, Onvo. The factory in Huainan will initially produce 100,000 units, scaling up to 600,000 annually.
Elliott Management Rebuilds Significant Stake In Masayoshi Son’s Softbank, Pushes For $15B Share Buyback: Report
The fund's move comes as the gap between SoftBank's asset value and its market valuation reaches unprecedented levels.
Tesla Investor Ross Gerber Thinks Elon Musk’s Decision To Redirect Nvidia AI Chips To X, xAI Is A ‘Weird Excuse’
Gerber added that Musk's motivation for diverting the chips is to focus on robotics and "robotaxi idea" at xAI over autonomous self-driving.
Poppi Faces Class-Action Lawsuit Over Misleading Gut Health Claims, Soda Maker Calls Allegations Unfounded
Poppi is being sued for allegedly misleading consumers with its prebiotic soda health claims, which a customer argues…
Microsoft To Fund Startup That Enhances AI Deployment
Touchcast Inc., a startup focused on caching generative AI queries, is set to raise $100 million from venture backers, including Microsoft Corp. The New York-based company aims to reduce computational and energy requirements for models like OpenAI's GPT-4. CEO Edo Segal expects the new funding to push Touchcast's valuation to at least $350 million.
MangoRx Gets Patent Notice Of Allowance In Japan For Revolutionary Preventive Care Technology
Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ED), hair
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection
The US National Institutes of Health has launched two clinical trials to test a new long-acting form of HIV PrEP in cisgender women and people who inject drugs. These mid-stage studies will evaluate the safety and pharmacokinetics of lenacapavir, a bi-annual injectable antiretroviral drug.
Open Letter For AI Companies Calls For Better Transparency, Protections For Whistleblowers
The letter signed by current and former employees at OpenAI, Anthropic, and Google DeepMind, said AI can exacerbate inequality, increase misinformation and allow weapons systems to become autonomous and cause significant death.
BridgeBio Pharma Shares One Year Data From Dwarfism Candidate
BridgeBio Pharma revealed results from the PROPEL 2 Phase 2 trial of infigratinib in children with achondroplasia. Key data shows sustained increases in height velocity and improved body proportionality with a good safety profile.